{"id":459414,"date":"2026-01-25T00:30:00","date_gmt":"2026-01-24T23:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=459414"},"modified":"2026-01-25T09:27:38","modified_gmt":"2026-01-25T08:27:38","slug":"cardiomiopatia-hipertrofica-obstrutiva-sintomatica","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/cardiomiopatia-hipertrofica-obstrutiva-sintomatica\/","title":{"rendered":"Cardiomiopatia hipertr\u00f3fica obstrutiva sintom\u00e1tica"},"content":{"rendered":"\n<p><strong>A inibi\u00e7\u00e3o da miosina \u00e9 considerada uma abordagem terap\u00eautica fundamental no tratamento da cardiomiopatia hipertr\u00f3fica obstrutiva (oHCM). Para al\u00e9m do mavacamten, o aficamten est\u00e1 agora a ser clinicamente investigado como um inibidor espec\u00edfico da miosina de a\u00e7\u00e3o potencialmente curta. O estudo FOREST-HCM \u00e9 o primeiro a fornecer dados sistematicamente recolhidos ao longo de 48 semanas sobre a efic\u00e1cia, a seguran\u00e7a e as altera\u00e7\u00f5es funcionais do tratamento a longo prazo. Os resultados fornecem informa\u00e7\u00f5es relevantes sobre a estabilidade da redu\u00e7\u00e3o do gradiente, o controlo dos sintomas e a tolerabilidade do medicamento em uso cont\u00ednuo.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fcardiomiopatia-hipertrofica-obstrutiva-sintomatica%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>A inibi\u00e7\u00e3o da miosina \u00e9 considerada uma abordagem terap\u00eautica fundamental no tratamento da cardiomiopatia hipertr\u00f3fica obstrutiva (oHCM). Para al\u00e9m do mavacamten, o aficamten est\u00e1 agora a ser clinicamente investigado como&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fcardiomiopatia-hipertrofica-obstrutiva-sintomatica%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":459415,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Resultados do estudo FOREST HCM  ","footnotes":""},"category":[11367,11521,11524,11551],"tags":[87419,14817,87420,87421,34870,87418,87422],"powerkit_post_featured":[],"class_list":["post-459414","post","type-post","status-publish","format-standard","has-post-thumbnail","category-cardiologia-pt-pt","category-estudos","category-formacao-continua","category-rx-pt","tag-aficamten","tag-cardiomiopatia-pt-pt","tag-floresta","tag-kccq","tag-lvot-pt-pt","tag-miosina","tag-nt-probnp","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-02 04:32:47","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":459411,"slug":"miocardiopatia-hipertrofica-obstructiva-sintomatica","post_title":"Miocardiopat\u00eda hipertr\u00f3fica obstructiva sintom\u00e1tica","href":"https:\/\/medizinonline.com\/es\/miocardiopatia-hipertrofica-obstructiva-sintomatica\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/459414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=459414"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/459414\/revisions"}],"predecessor-version":[{"id":459416,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/459414\/revisions\/459416"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/459415"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=459414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=459414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=459414"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=459414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}